Kyung Dong Pharmaceutical Co. Ltd (011040) - Total Assets
Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) holds total assets worth ₩321.90 Billion KRW (≈ $218.14 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Kyung Dong Pharmaceutical Co. Ltd for net asset value and shareholders' equity analysis.
Kyung Dong Pharmaceutical Co. Ltd - Total Assets Trend (2011–2025)
This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's total assets have evolved over time, based on quarterly financial data.
Kyung Dong Pharmaceutical Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Kyung Dong Pharmaceutical Co. Ltd's total assets of ₩321.90 Billion consist of 35.0% current assets and 65.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 9.9% |
| Accounts Receivable | ₩20.92 Billion | 6.5% |
| Inventory | ₩42.90 Billion | 13.3% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩9.70 Billion | 3.0% |
| Goodwill | ₩61.20 Million | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 011040 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kyung Dong Pharmaceutical Co. Ltd's current assets represent 35.0% of total assets in 2025, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2025, down from 12.9% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 1.0% in 2011.
- Asset Diversification: The largest asset category is inventory at 13.3% of total assets.
Kyung Dong Pharmaceutical Co. Ltd Competitors by Total Assets
Key competitors of Kyung Dong Pharmaceutical Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Komipharm International Co. Ltd
KQ:041960
|
Korea | ₩133.65 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩233.98 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩87.88 Billion |
|
Huons Global Co. Ltd
KQ:084110
|
Korea | ₩1.47 Trillion |
Kyung Dong Pharmaceutical Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.62 | 1.30 | 3.30 |
| Quick Ratio | 1.00 | 0.73 | 2.41 |
| Cash Ratio | 0.00 | 0.20 | 0.00 |
| Working Capital | ₩43.17 Billion | ₩23.40 Billion | ₩78.10 Billion |
Kyung Dong Pharmaceutical Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Kyung Dong Pharmaceutical Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.64 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.3% |
| Total Assets | ₩321.90 Billion |
| Market Capitalization | $89.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kyung Dong Pharmaceutical Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Kyung Dong Pharmaceutical Co. Ltd's assets grew by 6.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
The table below shows the annual total assets of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩321.90 Billion ≈ $218.14 Million |
+6.28% |
| 2024-12-31 | ₩302.87 Billion ≈ $205.25 Million |
+3.38% |
| 2023-12-31 | ₩292.97 Billion ≈ $198.54 Million |
-5.64% |
| 2022-12-31 | ₩310.48 Billion ≈ $210.41 Million |
+6.34% |
| 2021-12-31 | ₩291.97 Billion ≈ $197.87 Million |
+0.20% |
| 2020-12-31 | ₩291.39 Billion ≈ $197.47 Million |
+1.32% |
| 2019-12-31 | ₩287.59 Billion ≈ $194.90 Million |
+11.56% |
| 2018-12-31 | ₩257.79 Billion ≈ $174.70 Million |
+2.53% |
| 2017-12-31 | ₩251.43 Billion ≈ $170.39 Million |
+5.43% |
| 2016-12-31 | ₩238.49 Billion ≈ $161.62 Million |
+2.18% |
| 2015-12-31 | ₩233.41 Billion ≈ $158.18 Million |
+2.52% |
| 2014-12-31 | ₩227.68 Billion ≈ $154.30 Million |
+13.62% |
| 2013-12-31 | ₩200.39 Billion ≈ $135.80 Million |
+5.89% |
| 2012-12-31 | ₩189.23 Billion ≈ $128.24 Million |
+1.89% |
| 2011-12-31 | ₩185.72 Billion ≈ $125.86 Million |
-- |
About Kyung Dong Pharmaceutical Co. Ltd
Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, ant… Read more